Paul Hassie

Paul Hassie has a long history of professional experience, beginning with a Senior Manager role at Ernst & Young in 1984. Paul then moved to Transkaryotic Therapies, Inc. in 1991 as Controller. In 1997, they became CFO of USBiomaterials Corp. Two years later, they were appointed President of BioFlorida, Inc. In 2004, they became CFO of Oragenics, Inc. and then in 2010, they were appointed VP Finance at Banyan Biomarkers, Inc., a role they have held for the past 10 years.

Paul Hassie's education history includes four degrees from Bryant University. Paul earned a BS in Business Education in 1972, a BS in Accounting in 1977, an MBS in Management in 1982, and an MS in Taxation in 1996.